HHS launches clinical trial reforms — including new pilot programs and updated FDA guidance — to accelerate US drug development and compete with China.

The FDA and the NIH are streamlining clinical trial research guidelines to bolster U.S. biotech, calling it "Operation Trial Blazer."

Federal health officials aim to speed up drug development and better compete with China.